Vazirani Asset Management’s Exact Sciences EXAS Stock Holding History

Vazirani Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,000	Closed	-$2.54M	–	23
2025 Q4	$2.54M	Buy	+25,000	New	+$2.01M	15.41%	3

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vazirani Asset Management's EXAS Position: Q1 2026 in Review

Vazirani Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 25,000 shares — an estimated $2.54M sold.

Vazirani Asset Management first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $2.54M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Vazirani Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Vazirani Asset Management sold 25,000 Exact Sciences shares in Q1 2026, an estimated $2.54M.
Vazirani Asset Management first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
Vazirani Asset Management's Exact Sciences position peaked at $2.54M in Q4 2025.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Vazirani Asset Management's 13F filing for Q1 2026, filed 15 May 2026.